Nationwide Fund Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-38,350	Closed	-$1.45M	–	22
2017 Q3	$1.45M	Buy	38,350 +11,410	+42%	+$371K	0.01%	1599
2017 Q2	$751K	Buy	26,940 +14,600	+118%	+$435K	﹤0.01%	1952
2017 Q1	$424K	Buy	+12,340	New	+$436K	﹤0.01%	2241
2016 Q4	–	Sell	-36,330	Closed	-$1.16M	–	3192
2016 Q3	$1.16M	Buy	36,330 +9,010	+33%	+$305K	﹤0.01%	1690
2016 Q2	$887K	Sell	27,320 -27,227	-50%	-$911K	﹤0.01%	1801
2016 Q1	$1.55M	Sell	54,547 -12,096	-18%	-$264K	0.01%	1477
2015 Q4	$2.38M	Buy	66,643 +15,282	+30%	+$538K	0.01%	1285
2015 Q3	$1.7M	Sell	51,361 -281	-0.5%	-$11.7K	0.01%	1455
2015 Q2	$2.16M	Sell	51,642 -70,916	-58%	-$2.74M	0.01%	1389
2015 Q1	$3.99M	Buy	122,558 +62,669	+105%	+$2.15M	0.02%	1093
2014 Q4	$1.9M	Sell	59,889 -746	-1%	-$21.2K	0.01%	1442
2014 Q3	$1.5M	Buy	60,635 +14	+0%	+$327	0.01%	1599
2014 Q2	$1.37M	Buy	+60,621	New	+$1.27M	0.01%	1697
2014 Q1	–	Sell	-54,212	Closed	-$1.35M	–	3052
2013 Q4	$1.35M	Sell	54,212 -1,533	-3%	-$36.2K	0.01%	1699
2013 Q3	$1.53M	Buy	55,745 +33,211	+147%	+$694K	0.01%	1596
2013 Q2	$409K	Buy	+22,534	New	+$310K	﹤0.01%	2105